• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性及继发性机化性肺炎:临床表现、影像学表现、治疗反应和预后。

Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis.

机构信息

Third Pulmonary Medicine Department, Sismanoglion General Hospital, Maroussi, Greece.

Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Brown University, Providence, RI.

出版信息

Chest. 2011 Apr;139(4):893-900. doi: 10.1378/chest.10-0883. Epub 2010 Aug 19.

DOI:10.1378/chest.10-0883
PMID:20724743
Abstract

BACKGROUND

Organizing pneumonia (OP) is a distinct clinical and pathologic entity. This condition can be cryptogenic (COP) or secondary to other known causes (secondary OP). In the present study, we reviewed the features associated with COP and secondary OP in patients from two teaching hospitals.

METHODS

The medical records of 61 patients with biopsy-proven OP were retrospectively reviewed. Forty patients were diagnosed with COP and 21 patients with secondary OP. The clinical presentation, radiographic studies, pulmonary function tests (PFTs), laboratory data, BAL findings, treatment, and outcome were analyzed.

RESULTS

The mean age at presentation was 60.46 ± 13.57 years. Malaise, cough, fever, dyspnea, bilateral alveolar infiltrates, and a restrictive pattern were the most common symptoms and findings. BAL lymphocytosis was observed in 43.8% of patients with OP. The relapse rate and mortality rate after 1 year of follow-up were 37.8% and 9.4%, respectively. The in-hospital mortality was 5.7%. The clinical presentation and radiographic findings did not differ significantly between patients with COP and secondary OP. A mixed PFT pattern (obstructive and restrictive physiology) and lower blood levels of serum sodium, serum potassium, platelets, albumin, protein, and pH were observed among patients with secondary OP. Higher blood levels of creatinine, bilirubin, Paco₂, and BAL lymphocytes were also more common among patients with secondary OP. There were no differences in the relapse rate or mortality between patients with COP and secondary OP. The 1-year mortality correlated with an elevated erythrocyte sedimentation rate, low albumin, and low hemoglobin levels.

CONCLUSIONS

The clinical and radiographic findings in patients with COP and secondary OP are similar and nonspecific. Although certain laboratory abnormalities are more common in secondary OP and can be associated with worse prognosis, they are likely due to the underlying disease. COP and secondary OP have similar treatment response, relapse rates, and mortality.

摘要

背景

机化性肺炎(OP)是一种独特的临床和病理实体。这种情况可能是特发性的(COP),也可能继发于其他已知原因(继发性 OP)。在本研究中,我们回顾了两家教学医院的 COP 和继发性 OP 患者的相关特征。

方法

回顾性分析了 61 例经活检证实的 OP 患者的病历。40 例患者被诊断为 COP,21 例患者为继发性 OP。分析了临床表现、影像学研究、肺功能检查(PFT)、实验室数据、BAL 结果、治疗和预后。

结果

发病时的平均年龄为 60.46±13.57 岁。最常见的症状和表现为不适、咳嗽、发热、呼吸困难、双侧肺泡浸润和限制性模式。43.8%的 OP 患者 BAL 淋巴细胞增多。1 年后的复发率和死亡率分别为 37.8%和 9.4%。住院死亡率为 5.7%。COP 和继发性 OP 患者的临床表现和影像学表现无显著差异。继发性 OP 患者存在混合性 PFT 模式(阻塞性和限制性生理学)和较低的血清钠、血清钾、血小板、白蛋白、蛋白和 pH 值。继发性 OP 患者还更常见较高的血肌酐、胆红素、Paco₂和 BAL 淋巴细胞水平。COP 和继发性 OP 患者的复发率或死亡率无差异。1 年死亡率与红细胞沉降率升高、白蛋白和血红蛋白水平降低有关。

结论

COP 和继发性 OP 患者的临床和影像学表现相似且无特异性。虽然某些实验室异常在继发性 OP 中更为常见,并且可能与预后较差相关,但这些异常可能是由基础疾病引起的。COP 和继发性 OP 的治疗反应、复发率和死亡率相似。

相似文献

1
Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis.特发性及继发性机化性肺炎:临床表现、影像学表现、治疗反应和预后。
Chest. 2011 Apr;139(4):893-900. doi: 10.1378/chest.10-0883. Epub 2010 Aug 19.
2
A long-term retrospective study of patients with biopsy-proven cryptogenic organizing pneumonia.经活检证实为隐源性机化性肺炎患者的长期回顾性研究。
Chron Respir Dis. 2019 Jan-Dec;16:1479973119853829. doi: 10.1177/1479973119853829.
3
Comparison of clinical features and prognosis in patients with cryptogenic and secondary organizing pneumonia.隐源性和继发性机化性肺炎患者的临床特征和预后比较。
BMC Pulm Med. 2021 Oct 29;21(1):336. doi: 10.1186/s12890-021-01707-z.
4
Comparison between cryptogenic organizing pneumonia and connective tissue disease-related organizing pneumonia.隐源性机化性肺炎与结缔组织病相关机化性肺炎的比较。
Rheumatology (Oxford). 2011 May;50(5):932-8. doi: 10.1093/rheumatology/keq410. Epub 2010 Dec 17.
5
Clinical features in secondary and cryptogenic organising pneumonia.继发性和隐源性机化性肺炎的临床特征。
Int J Tuberc Lung Dis. 2007 Jun;11(6):689-94.
6
Chest CT imaging features for prediction of treatment response in cryptogenic and connective tissue disease-related organizing pneumonia.胸部 CT 影像学特征预测隐源性及结缔组织病相关机化性肺炎的治疗反应。
Eur Radiol. 2020 May;30(5):2722-2730. doi: 10.1007/s00330-019-06651-5. Epub 2020 Feb 10.
7
Organizing pneumonia. Features and prognosis of cryptogenic, secondary, and focal variants.机化性肺炎。特发性、继发性和局灶性变体的特征与预后
Arch Intern Med. 1997 Jun 23;157(12):1323-9. doi: 10.1001/archinte.157.12.1323.
8
Bronchiolitis obliterans-organizing pneumonia: an Italian experience.闭塞性细支气管炎伴机化性肺炎:意大利的经验。
Respir Med. 2000 Jul;94(7):702-8. doi: 10.1053/rmed.2000.0805.
9
Clinical and radiologic distinctions between secondary bronchiolitis obliterans organizing pneumonia and cryptogenic organizing pneumonia.继发性闭塞性细支气管炎机化性肺炎与隐源性机化性肺炎的临床及影像学鉴别
Respir Care. 2009 Aug;54(8):1028-32.
10
[Organising Pneumonia - a review and results from Icelandic studies].[机化性肺炎——冰岛研究综述及结果]
Laeknabladid. 2008 Jan;94(1):27-35.

引用本文的文献

1
Korean Guidelines for Diagnosis and Management of Interstitial Lung Disease: Cryptogenic Organizing Pneumonia.韩国间质性肺疾病诊断与管理指南:隐源性机化性肺炎
Tuberc Respir Dis (Seoul). 2025 Jul;88(3):477-487. doi: 10.4046/trd.2024.0167. Epub 2025 Mar 13.
2
Management of Severe SARS-CoV-2-Associated Organizing Pneumonia With Immunoglobulins.使用免疫球蛋白治疗严重的新型冠状病毒2型相关机化性肺炎
Cureus. 2025 Jan 8;17(1):e77120. doi: 10.7759/cureus.77120. eCollection 2025 Jan.
3
Secondary organizing pneumonia after infection.感染后继发性机化性肺炎
World J Clin Cases. 2024 Dec 26;12(36):6877-6882. doi: 10.12998/wjcc.v12.i36.6877.
4
Pulmonary Manifestations of IBD: Case Report and Review of the Literature.炎症性肠病的肺部表现:病例报告及文献综述
J Clin Med. 2024 Sep 12;13(18):5401. doi: 10.3390/jcm13185401.
5
Cryptogenic organizing pneumonia: clinical outcomes of 60 consecutive cases.隐源性机化性肺炎:60例连续病例的临床结局
J Thorac Dis. 2024 May 31;16(5):3129-3141. doi: 10.21037/jtd-24-225. Epub 2024 May 17.
6
Rapidly Progressing Secondary Organizing Pneumonia Due to Underlying Immunosuppression With Rituximab in SARS-CoV-2 Patients.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染患者中,因使用利妥昔单抗导致潜在免疫抑制而引发的快速进展性继发性机化性肺炎
Cureus. 2024 May 15;16(5):e60328. doi: 10.7759/cureus.60328. eCollection 2024 May.
7
Corticosteroid treatment for persistent pulmonary infiltrates following COVID-19 infection: Clearing the fog?新冠病毒感染后持续性肺部浸润的皮质类固醇治疗:拨开迷雾?
Ann Thorac Med. 2024 Jan-Mar;19(1):74-80. doi: 10.4103/atm.atm_121_23. Epub 2024 Jan 25.
8
Organizing pneumonia secondary to pulmonary cryptococcosis in immunocompromised patient.免疫功能低下患者继发于肺隐球菌病的机化性肺炎。
Respir Med Case Rep. 2023 Dec 29;47:101975. doi: 10.1016/j.rmcr.2023.101975. eCollection 2024.
9
Case report: Coexistence of triple-seronegative myasthenia gravis and pathology-proven cryptogenic organizing pneumonia.病例报告:三阴性重症肌无力与病理证实的隐源性机化性肺炎并存。
Front Neurol. 2023 Nov 16;14:1295374. doi: 10.3389/fneur.2023.1295374. eCollection 2023.
10
Systematic Review of Systemic Corticosteroids for Treatment of Organizing Pneumonia.系统性皮质类固醇治疗机化性肺炎的系统评价
Open Respir Arch. 2022 Sep 19;4(4):100211. doi: 10.1016/j.opresp.2022.100211. eCollection 2022 Oct-Dec.